Literature DB >> 1486190

Gall-bladder sludge: lessons from ceftriaxone.

Y S Kim1, M F Kestell, S P Lee.   

Abstract

Ceftriaxone-associated sludge has been a fascinating story. The occurrence is novel and unique. It has produced a model of gall-bladder sludge in humans. This phenomenon has taught us a great deal about biliary lipid and organic anion excretion by the liver, and the physical chemistry of calcium and calcium sensitive anions. It has added further insights into the pathophysiology of gall-bladder sludge formation. It points to a combination of a hepatic effect where the liver secretes a biochemically abnormal bile, and a gall-bladder effect which provides an environment for precipitation, in order for sludge to develop. The precipitated calcium ceftriaxone has prompted us to re-evaluate the imaging criteria for the diagnosis of gall-bladder sludge versus gallstones. Above all, the rapid onset and rapid disappearance of ceftriaxone sludge has mirrored in a compressed, encapsulated form, the natural history of gall-bladder sludge. It has reminded us that, like gallstones, biliary sludge is usually benign and asymptomatic. However just because it is smaller than gallstones does not mean it cannot cause problems. It can disappear or it can become a calcium ceftriaxone gallstone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1486190     DOI: 10.1111/j.1440-1746.1992.tb01496.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

Review 1.  Gallbladder sludge: what is its clinical significance?

Authors:  E A Shaffer
Journal:  Curr Gastroenterol Rep       Date:  2001-04

2.  A symptomatic child with ceftriaxone-associated biliary pseudolithiasis.

Authors:  Naoki Kutuya; Yutaka Ozaki; Tadaharu Okazaki
Journal:  J Med Ultrason (2001)       Date:  2008-09-19       Impact factor: 1.314

3.  Ceftriaxone-induced pseudolithiasis: not just a theoretical risk.

Authors:  Lijia Fan; Perry Lau; Jeevesh Kapur; Sivaramakrishnan Venkatesh Karthik
Journal:  Singapore Med J       Date:  2017-11       Impact factor: 1.858

Review 4.  Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.

Authors:  Harriet M Lamb; Douglas Ormrod; Lesley J Scott; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  Evaluation of a potential clinical interaction between ceftriaxone and calcium.

Authors:  Emily Steadman; Dennis W Raisch; Charles L Bennett; John S Esterly; Tischa Becker; Michael Postelnick; June M McKoy; Steve Trifilio; Paul R Yarnold; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

6.  Is Ceftriaxone-Induced Biliary Pseudolithiasis Influenced by UDP-Glucuronosyltransferase 1A1 Gene Polymorphisms?

Authors:  Andrew Fretzayas; Olga Liapi; Anna Papadopoulou; Polyxeni Nicolaidou; Alexandra Stamoulakatou
Journal:  Case Rep Med       Date:  2011-10-26

7.  Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study.

Authors:  Min H Kang; Judith G Villablanca; Julia L Glade Bender; Katherine K Matthay; Susan Groshen; Richard Sposto; Scarlett Czarnecki; Matthew M Ames; C Patrick Reynolds; Araz Marachelian; Barry J Maurer
Journal:  BMC Res Notes       Date:  2014-04-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.